BMC BIOINFORMATICS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2168270, encodeId=b7d121682e052, content=投稿命中率:50.0 偏重的研究方向：甲基化诊断建模;纯生信 经验分享：纯生信被拒了，上周投的，上传完manuscript两小时后技术审查结束，修改了一下技术审查的问题之后，技术审查通过，然后没过几小时就拒了（泪目）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad649033463, createdName=ms6000001436673451, createdTime=Mon Nov 13 14:47:56 CST 2023, time=2023-11-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1013819, encodeId=5468101381969, content=偏重的研究方向：生物信息学 经验分享：纯生信可以吗?有人投过纯生信接收的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Thu Sep 02 17:57:13 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129243, encodeId=460b212924326, content=审稿速度:2.0 经验分享：纯生信 2个月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7655496527, createdName=ms4000000699988821, createdTime=Sat Apr 29 16:18:15 CST 2023, time=2023-04-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1000355, encodeId=e00a10003552c, content=Quality check in progress 15天了，大家都是这么久嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65a15502615, createdName=皮皮02, createdTime=Sat Jul 17 12:14:46 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103965, encodeId=684021039654c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：单基因泛癌分析;生信 经验分享：单基因泛癌分析，并在胃癌中有表达验证。 投稿20多天，编辑这直接拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Fri Dec 02 17:27:17 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1238224, encodeId=62a0123822440, content=不接受纯生信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=979b2249482, createdName=12160191m01暂无昵称, createdTime=Fri Aug 12 09:22:35 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996999, encodeId=0bba99699967, content=这个审稿快不快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65a15502615, createdName=皮皮02, createdTime=Wed Jul 07 08:57:36 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590587, encodeId=cdd159058eae, content=我刚投了，在技术审核阶段，不晓得能不能通过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Sun May 10 00:00:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567249, encodeId=3b8756e249dd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：一审阶段：2018.06.06~2018.08.20，被拒，接受修改后再投 二审阶段：2018.09.22~2018.11.08，被拒，接受修改后再投 三审阶段：2018.11.18~2018.12.08，被拒，不可再投 欢迎关住生信算法，一起交流学习，附审稿意见download，关注后回复bmc即可, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=NspicTOL6XtFWgupDw26HOw&s=100, createdBy=c81c2554596, createdName=生信算法公众号, createdTime=Mon Feb 25 17:49:00 CST 2019, time=2019-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077517, encodeId=a94810e7517db, content=唉，被transfer了，但杂志也没有说transfer到了哪里，说是系统的一个刊物, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daf95314919, createdName=1489665dm23暂无昵称, createdTime=Mon Dec 06 21:41:01 CST 2021, time=2021-12-06, status=1, ipAttribution=)]

2023-11-13 ms6000001436673451 来自广东省

投稿命中率:50.0
偏重的研究方向：甲基化诊断建模;纯生信
经验分享：纯生信被拒了，上周投的，上传完manuscript两小时后技术审查结束，修改了一下技术审查的问题之后，技术审查通过，然后没过几小时就拒了（泪目）

29 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2168270, encodeId=b7d121682e052, content=投稿命中率:50.0 偏重的研究方向：甲基化诊断建模;纯生信 经验分享：纯生信被拒了，上周投的，上传完manuscript两小时后技术审查结束，修改了一下技术审查的问题之后，技术审查通过，然后没过几小时就拒了（泪目）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad649033463, createdName=ms6000001436673451, createdTime=Mon Nov 13 14:47:56 CST 2023, time=2023-11-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1013819, encodeId=5468101381969, content=偏重的研究方向：生物信息学 经验分享：纯生信可以吗?有人投过纯生信接收的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Thu Sep 02 17:57:13 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129243, encodeId=460b212924326, content=审稿速度:2.0 经验分享：纯生信 2个月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7655496527, createdName=ms4000000699988821, createdTime=Sat Apr 29 16:18:15 CST 2023, time=2023-04-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1000355, encodeId=e00a10003552c, content=Quality check in progress 15天了，大家都是这么久嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65a15502615, createdName=皮皮02, createdTime=Sat Jul 17 12:14:46 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103965, encodeId=684021039654c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：单基因泛癌分析;生信 经验分享：单基因泛癌分析，并在胃癌中有表达验证。 投稿20多天，编辑这直接拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Fri Dec 02 17:27:17 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1238224, encodeId=62a0123822440, content=不接受纯生信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=979b2249482, createdName=12160191m01暂无昵称, createdTime=Fri Aug 12 09:22:35 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996999, encodeId=0bba99699967, content=这个审稿快不快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65a15502615, createdName=皮皮02, createdTime=Wed Jul 07 08:57:36 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590587, encodeId=cdd159058eae, content=我刚投了，在技术审核阶段，不晓得能不能通过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Sun May 10 00:00:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567249, encodeId=3b8756e249dd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：一审阶段：2018.06.06~2018.08.20，被拒，接受修改后再投 二审阶段：2018.09.22~2018.11.08，被拒，接受修改后再投 三审阶段：2018.11.18~2018.12.08，被拒，不可再投 欢迎关住生信算法，一起交流学习，附审稿意见download，关注后回复bmc即可, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=NspicTOL6XtFWgupDw26HOw&s=100, createdBy=c81c2554596, createdName=生信算法公众号, createdTime=Mon Feb 25 17:49:00 CST 2019, time=2019-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077517, encodeId=a94810e7517db, content=唉，被transfer了，但杂志也没有说transfer到了哪里，说是系统的一个刊物, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daf95314919, createdName=1489665dm23暂无昵称, createdTime=Mon Dec 06 21:41:01 CST 2021, time=2021-12-06, status=1, ipAttribution=)]

2021-09-02 wsasdeffgcf

偏重的研究方向：生物信息学
经验分享：纯生信可以吗?有人投过纯生信接收的吗?

0 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2168270, encodeId=b7d121682e052, content=投稿命中率:50.0 偏重的研究方向：甲基化诊断建模;纯生信 经验分享：纯生信被拒了，上周投的，上传完manuscript两小时后技术审查结束，修改了一下技术审查的问题之后，技术审查通过，然后没过几小时就拒了（泪目）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad649033463, createdName=ms6000001436673451, createdTime=Mon Nov 13 14:47:56 CST 2023, time=2023-11-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1013819, encodeId=5468101381969, content=偏重的研究方向：生物信息学 经验分享：纯生信可以吗?有人投过纯生信接收的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Thu Sep 02 17:57:13 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129243, encodeId=460b212924326, content=审稿速度:2.0 经验分享：纯生信 2个月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7655496527, createdName=ms4000000699988821, createdTime=Sat Apr 29 16:18:15 CST 2023, time=2023-04-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1000355, encodeId=e00a10003552c, content=Quality check in progress 15天了，大家都是这么久嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65a15502615, createdName=皮皮02, createdTime=Sat Jul 17 12:14:46 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103965, encodeId=684021039654c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：单基因泛癌分析;生信 经验分享：单基因泛癌分析，并在胃癌中有表达验证。 投稿20多天，编辑这直接拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Fri Dec 02 17:27:17 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1238224, encodeId=62a0123822440, content=不接受纯生信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=979b2249482, createdName=12160191m01暂无昵称, createdTime=Fri Aug 12 09:22:35 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996999, encodeId=0bba99699967, content=这个审稿快不快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65a15502615, createdName=皮皮02, createdTime=Wed Jul 07 08:57:36 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590587, encodeId=cdd159058eae, content=我刚投了，在技术审核阶段，不晓得能不能通过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Sun May 10 00:00:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567249, encodeId=3b8756e249dd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：一审阶段：2018.06.06~2018.08.20，被拒，接受修改后再投 二审阶段：2018.09.22~2018.11.08，被拒，接受修改后再投 三审阶段：2018.11.18~2018.12.08，被拒，不可再投 欢迎关住生信算法，一起交流学习，附审稿意见download，关注后回复bmc即可, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=NspicTOL6XtFWgupDw26HOw&s=100, createdBy=c81c2554596, createdName=生信算法公众号, createdTime=Mon Feb 25 17:49:00 CST 2019, time=2019-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077517, encodeId=a94810e7517db, content=唉，被transfer了，但杂志也没有说transfer到了哪里，说是系统的一个刊物, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daf95314919, createdName=1489665dm23暂无昵称, createdTime=Mon Dec 06 21:41:01 CST 2021, time=2021-12-06, status=1, ipAttribution=)]

2023-04-29 ms4000000699988821 来自浙江省

审稿速度:2.0
经验分享：纯生信 2个月接受

42 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2168270, encodeId=b7d121682e052, content=投稿命中率:50.0 偏重的研究方向：甲基化诊断建模;纯生信 经验分享：纯生信被拒了，上周投的，上传完manuscript两小时后技术审查结束，修改了一下技术审查的问题之后，技术审查通过，然后没过几小时就拒了（泪目）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad649033463, createdName=ms6000001436673451, createdTime=Mon Nov 13 14:47:56 CST 2023, time=2023-11-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1013819, encodeId=5468101381969, content=偏重的研究方向：生物信息学 经验分享：纯生信可以吗?有人投过纯生信接收的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Thu Sep 02 17:57:13 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129243, encodeId=460b212924326, content=审稿速度:2.0 经验分享：纯生信 2个月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7655496527, createdName=ms4000000699988821, createdTime=Sat Apr 29 16:18:15 CST 2023, time=2023-04-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1000355, encodeId=e00a10003552c, content=Quality check in progress 15天了，大家都是这么久嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65a15502615, createdName=皮皮02, createdTime=Sat Jul 17 12:14:46 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103965, encodeId=684021039654c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：单基因泛癌分析;生信 经验分享：单基因泛癌分析，并在胃癌中有表达验证。 投稿20多天，编辑这直接拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Fri Dec 02 17:27:17 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1238224, encodeId=62a0123822440, content=不接受纯生信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=979b2249482, createdName=12160191m01暂无昵称, createdTime=Fri Aug 12 09:22:35 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996999, encodeId=0bba99699967, content=这个审稿快不快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65a15502615, createdName=皮皮02, createdTime=Wed Jul 07 08:57:36 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590587, encodeId=cdd159058eae, content=我刚投了，在技术审核阶段，不晓得能不能通过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Sun May 10 00:00:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567249, encodeId=3b8756e249dd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：一审阶段：2018.06.06~2018.08.20，被拒，接受修改后再投 二审阶段：2018.09.22~2018.11.08，被拒，接受修改后再投 三审阶段：2018.11.18~2018.12.08，被拒，不可再投 欢迎关住生信算法，一起交流学习，附审稿意见download，关注后回复bmc即可, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=NspicTOL6XtFWgupDw26HOw&s=100, createdBy=c81c2554596, createdName=生信算法公众号, createdTime=Mon Feb 25 17:49:00 CST 2019, time=2019-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077517, encodeId=a94810e7517db, content=唉，被transfer了，但杂志也没有说transfer到了哪里，说是系统的一个刊物, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daf95314919, createdName=1489665dm23暂无昵称, createdTime=Mon Dec 06 21:41:01 CST 2021, time=2021-12-06, status=1, ipAttribution=)]

2021-07-17 皮皮02

Quality check in progress 15天了，大家都是这么久嘛

61 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2168270, encodeId=b7d121682e052, content=投稿命中率:50.0 偏重的研究方向：甲基化诊断建模;纯生信 经验分享：纯生信被拒了，上周投的，上传完manuscript两小时后技术审查结束，修改了一下技术审查的问题之后，技术审查通过，然后没过几小时就拒了（泪目）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad649033463, createdName=ms6000001436673451, createdTime=Mon Nov 13 14:47:56 CST 2023, time=2023-11-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1013819, encodeId=5468101381969, content=偏重的研究方向：生物信息学 经验分享：纯生信可以吗?有人投过纯生信接收的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Thu Sep 02 17:57:13 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129243, encodeId=460b212924326, content=审稿速度:2.0 经验分享：纯生信 2个月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7655496527, createdName=ms4000000699988821, createdTime=Sat Apr 29 16:18:15 CST 2023, time=2023-04-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1000355, encodeId=e00a10003552c, content=Quality check in progress 15天了，大家都是这么久嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65a15502615, createdName=皮皮02, createdTime=Sat Jul 17 12:14:46 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103965, encodeId=684021039654c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：单基因泛癌分析;生信 经验分享：单基因泛癌分析，并在胃癌中有表达验证。 投稿20多天，编辑这直接拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Fri Dec 02 17:27:17 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1238224, encodeId=62a0123822440, content=不接受纯生信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=979b2249482, createdName=12160191m01暂无昵称, createdTime=Fri Aug 12 09:22:35 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996999, encodeId=0bba99699967, content=这个审稿快不快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65a15502615, createdName=皮皮02, createdTime=Wed Jul 07 08:57:36 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590587, encodeId=cdd159058eae, content=我刚投了，在技术审核阶段，不晓得能不能通过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Sun May 10 00:00:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567249, encodeId=3b8756e249dd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：一审阶段：2018.06.06~2018.08.20，被拒，接受修改后再投 二审阶段：2018.09.22~2018.11.08，被拒，接受修改后再投 三审阶段：2018.11.18~2018.12.08，被拒，不可再投 欢迎关住生信算法，一起交流学习，附审稿意见download，关注后回复bmc即可, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=NspicTOL6XtFWgupDw26HOw&s=100, createdBy=c81c2554596, createdName=生信算法公众号, createdTime=Mon Feb 25 17:49:00 CST 2019, time=2019-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077517, encodeId=a94810e7517db, content=唉，被transfer了，但杂志也没有说transfer到了哪里，说是系统的一个刊物, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daf95314919, createdName=1489665dm23暂无昵称, createdTime=Mon Dec 06 21:41:01 CST 2021, time=2021-12-06, status=1, ipAttribution=)]

2022-12-02 ms2000000713462597 来自广东省

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：单基因泛癌分析;生信
经验分享：单基因泛癌分析，并在胃癌中有表达验证。
投稿20多天，编辑这直接拒稿。

47 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2168270, encodeId=b7d121682e052, content=投稿命中率:50.0 偏重的研究方向：甲基化诊断建模;纯生信 经验分享：纯生信被拒了，上周投的，上传完manuscript两小时后技术审查结束，修改了一下技术审查的问题之后，技术审查通过，然后没过几小时就拒了（泪目）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad649033463, createdName=ms6000001436673451, createdTime=Mon Nov 13 14:47:56 CST 2023, time=2023-11-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1013819, encodeId=5468101381969, content=偏重的研究方向：生物信息学 经验分享：纯生信可以吗?有人投过纯生信接收的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Thu Sep 02 17:57:13 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129243, encodeId=460b212924326, content=审稿速度:2.0 经验分享：纯生信 2个月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7655496527, createdName=ms4000000699988821, createdTime=Sat Apr 29 16:18:15 CST 2023, time=2023-04-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1000355, encodeId=e00a10003552c, content=Quality check in progress 15天了，大家都是这么久嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65a15502615, createdName=皮皮02, createdTime=Sat Jul 17 12:14:46 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103965, encodeId=684021039654c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：单基因泛癌分析;生信 经验分享：单基因泛癌分析，并在胃癌中有表达验证。 投稿20多天，编辑这直接拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Fri Dec 02 17:27:17 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1238224, encodeId=62a0123822440, content=不接受纯生信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=979b2249482, createdName=12160191m01暂无昵称, createdTime=Fri Aug 12 09:22:35 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996999, encodeId=0bba99699967, content=这个审稿快不快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65a15502615, createdName=皮皮02, createdTime=Wed Jul 07 08:57:36 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590587, encodeId=cdd159058eae, content=我刚投了，在技术审核阶段，不晓得能不能通过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Sun May 10 00:00:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567249, encodeId=3b8756e249dd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：一审阶段：2018.06.06~2018.08.20，被拒，接受修改后再投 二审阶段：2018.09.22~2018.11.08，被拒，接受修改后再投 三审阶段：2018.11.18~2018.12.08，被拒，不可再投 欢迎关住生信算法，一起交流学习，附审稿意见download，关注后回复bmc即可, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=NspicTOL6XtFWgupDw26HOw&s=100, createdBy=c81c2554596, createdName=生信算法公众号, createdTime=Mon Feb 25 17:49:00 CST 2019, time=2019-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077517, encodeId=a94810e7517db, content=唉，被transfer了，但杂志也没有说transfer到了哪里，说是系统的一个刊物, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daf95314919, createdName=1489665dm23暂无昵称, createdTime=Mon Dec 06 21:41:01 CST 2021, time=2021-12-06, status=1, ipAttribution=)]

2022-08-12 12160191m01暂无昵称

不接受纯生信

52 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2168270, encodeId=b7d121682e052, content=投稿命中率:50.0 偏重的研究方向：甲基化诊断建模;纯生信 经验分享：纯生信被拒了，上周投的，上传完manuscript两小时后技术审查结束，修改了一下技术审查的问题之后，技术审查通过，然后没过几小时就拒了（泪目）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad649033463, createdName=ms6000001436673451, createdTime=Mon Nov 13 14:47:56 CST 2023, time=2023-11-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1013819, encodeId=5468101381969, content=偏重的研究方向：生物信息学 经验分享：纯生信可以吗?有人投过纯生信接收的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Thu Sep 02 17:57:13 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129243, encodeId=460b212924326, content=审稿速度:2.0 经验分享：纯生信 2个月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7655496527, createdName=ms4000000699988821, createdTime=Sat Apr 29 16:18:15 CST 2023, time=2023-04-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1000355, encodeId=e00a10003552c, content=Quality check in progress 15天了，大家都是这么久嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65a15502615, createdName=皮皮02, createdTime=Sat Jul 17 12:14:46 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103965, encodeId=684021039654c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：单基因泛癌分析;生信 经验分享：单基因泛癌分析，并在胃癌中有表达验证。 投稿20多天，编辑这直接拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Fri Dec 02 17:27:17 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1238224, encodeId=62a0123822440, content=不接受纯生信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=979b2249482, createdName=12160191m01暂无昵称, createdTime=Fri Aug 12 09:22:35 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996999, encodeId=0bba99699967, content=这个审稿快不快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65a15502615, createdName=皮皮02, createdTime=Wed Jul 07 08:57:36 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590587, encodeId=cdd159058eae, content=我刚投了，在技术审核阶段，不晓得能不能通过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Sun May 10 00:00:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567249, encodeId=3b8756e249dd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：一审阶段：2018.06.06~2018.08.20，被拒，接受修改后再投 二审阶段：2018.09.22~2018.11.08，被拒，接受修改后再投 三审阶段：2018.11.18~2018.12.08，被拒，不可再投 欢迎关住生信算法，一起交流学习，附审稿意见download，关注后回复bmc即可, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=NspicTOL6XtFWgupDw26HOw&s=100, createdBy=c81c2554596, createdName=生信算法公众号, createdTime=Mon Feb 25 17:49:00 CST 2019, time=2019-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077517, encodeId=a94810e7517db, content=唉，被transfer了，但杂志也没有说transfer到了哪里，说是系统的一个刊物, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daf95314919, createdName=1489665dm23暂无昵称, createdTime=Mon Dec 06 21:41:01 CST 2021, time=2021-12-06, status=1, ipAttribution=)]

2021-07-07 皮皮02

这个审稿快不快啊

75 0

[GetPortalCommentsPageByObjectIdResponse(id=2168270, encodeId=b7d121682e052, content=投稿命中率:50.0 偏重的研究方向：甲基化诊断建模;纯生信 经验分享：纯生信被拒了，上周投的，上传完manuscript两小时后技术审查结束，修改了一下技术审查的问题之后，技术审查通过，然后没过几小时就拒了（泪目）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad649033463, createdName=ms6000001436673451, createdTime=Mon Nov 13 14:47:56 CST 2023, time=2023-11-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1013819, encodeId=5468101381969, content=偏重的研究方向：生物信息学 经验分享：纯生信可以吗?有人投过纯生信接收的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Thu Sep 02 17:57:13 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129243, encodeId=460b212924326, content=审稿速度:2.0 经验分享：纯生信 2个月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7655496527, createdName=ms4000000699988821, createdTime=Sat Apr 29 16:18:15 CST 2023, time=2023-04-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1000355, encodeId=e00a10003552c, content=Quality check in progress 15天了，大家都是这么久嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65a15502615, createdName=皮皮02, createdTime=Sat Jul 17 12:14:46 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103965, encodeId=684021039654c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：单基因泛癌分析;生信 经验分享：单基因泛癌分析，并在胃癌中有表达验证。 投稿20多天，编辑这直接拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Fri Dec 02 17:27:17 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1238224, encodeId=62a0123822440, content=不接受纯生信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=979b2249482, createdName=12160191m01暂无昵称, createdTime=Fri Aug 12 09:22:35 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996999, encodeId=0bba99699967, content=这个审稿快不快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65a15502615, createdName=皮皮02, createdTime=Wed Jul 07 08:57:36 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590587, encodeId=cdd159058eae, content=我刚投了，在技术审核阶段，不晓得能不能通过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Sun May 10 00:00:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567249, encodeId=3b8756e249dd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：一审阶段：2018.06.06~2018.08.20，被拒，接受修改后再投 二审阶段：2018.09.22~2018.11.08，被拒，接受修改后再投 三审阶段：2018.11.18~2018.12.08，被拒，不可再投 欢迎关住生信算法，一起交流学习，附审稿意见download，关注后回复bmc即可, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=NspicTOL6XtFWgupDw26HOw&s=100, createdBy=c81c2554596, createdName=生信算法公众号, createdTime=Mon Feb 25 17:49:00 CST 2019, time=2019-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077517, encodeId=a94810e7517db, content=唉，被transfer了，但杂志也没有说transfer到了哪里，说是系统的一个刊物, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daf95314919, createdName=1489665dm23暂无昵称, createdTime=Mon Dec 06 21:41:01 CST 2021, time=2021-12-06, status=1, ipAttribution=)]

2020-05-10 zhanyu

我刚投了，在技术审核阶段，不晓得能不能通过

158 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2168270, encodeId=b7d121682e052, content=投稿命中率:50.0 偏重的研究方向：甲基化诊断建模;纯生信 经验分享：纯生信被拒了，上周投的，上传完manuscript两小时后技术审查结束，修改了一下技术审查的问题之后，技术审查通过，然后没过几小时就拒了（泪目）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad649033463, createdName=ms6000001436673451, createdTime=Mon Nov 13 14:47:56 CST 2023, time=2023-11-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1013819, encodeId=5468101381969, content=偏重的研究方向：生物信息学 经验分享：纯生信可以吗?有人投过纯生信接收的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Thu Sep 02 17:57:13 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129243, encodeId=460b212924326, content=审稿速度:2.0 经验分享：纯生信 2个月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7655496527, createdName=ms4000000699988821, createdTime=Sat Apr 29 16:18:15 CST 2023, time=2023-04-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1000355, encodeId=e00a10003552c, content=Quality check in progress 15天了，大家都是这么久嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65a15502615, createdName=皮皮02, createdTime=Sat Jul 17 12:14:46 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103965, encodeId=684021039654c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：单基因泛癌分析;生信 经验分享：单基因泛癌分析，并在胃癌中有表达验证。 投稿20多天，编辑这直接拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Fri Dec 02 17:27:17 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1238224, encodeId=62a0123822440, content=不接受纯生信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=979b2249482, createdName=12160191m01暂无昵称, createdTime=Fri Aug 12 09:22:35 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996999, encodeId=0bba99699967, content=这个审稿快不快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65a15502615, createdName=皮皮02, createdTime=Wed Jul 07 08:57:36 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590587, encodeId=cdd159058eae, content=我刚投了，在技术审核阶段，不晓得能不能通过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Sun May 10 00:00:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567249, encodeId=3b8756e249dd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：一审阶段：2018.06.06~2018.08.20，被拒，接受修改后再投 二审阶段：2018.09.22~2018.11.08，被拒，接受修改后再投 三审阶段：2018.11.18~2018.12.08，被拒，不可再投 欢迎关住生信算法，一起交流学习，附审稿意见download，关注后回复bmc即可, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=NspicTOL6XtFWgupDw26HOw&s=100, createdBy=c81c2554596, createdName=生信算法公众号, createdTime=Mon Feb 25 17:49:00 CST 2019, time=2019-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077517, encodeId=a94810e7517db, content=唉，被transfer了，但杂志也没有说transfer到了哪里，说是系统的一个刊物, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daf95314919, createdName=1489665dm23暂无昵称, createdTime=Mon Dec 06 21:41:01 CST 2021, time=2021-12-06, status=1, ipAttribution=)]

2019-02-25 生信算法公众号

审稿速度:6.0 | 投稿命中率:50.0
经验分享：一审阶段：2018.06.06~2018.08.20，被拒，接受修改后再投

二审阶段：2018.09.22~2018.11.08，被拒，接受修改后再投

三审阶段：2018.11.18~2018.12.08，被拒，不可再投
欢迎关住生信算法，一起交流学习，附审稿意见download，关注后回复bmc即可

221 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2168270, encodeId=b7d121682e052, content=投稿命中率:50.0 偏重的研究方向：甲基化诊断建模;纯生信 经验分享：纯生信被拒了，上周投的，上传完manuscript两小时后技术审查结束，修改了一下技术审查的问题之后，技术审查通过，然后没过几小时就拒了（泪目）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad649033463, createdName=ms6000001436673451, createdTime=Mon Nov 13 14:47:56 CST 2023, time=2023-11-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1013819, encodeId=5468101381969, content=偏重的研究方向：生物信息学 经验分享：纯生信可以吗?有人投过纯生信接收的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Thu Sep 02 17:57:13 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129243, encodeId=460b212924326, content=审稿速度:2.0 经验分享：纯生信 2个月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7655496527, createdName=ms4000000699988821, createdTime=Sat Apr 29 16:18:15 CST 2023, time=2023-04-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1000355, encodeId=e00a10003552c, content=Quality check in progress 15天了，大家都是这么久嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65a15502615, createdName=皮皮02, createdTime=Sat Jul 17 12:14:46 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103965, encodeId=684021039654c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：单基因泛癌分析;生信 经验分享：单基因泛癌分析，并在胃癌中有表达验证。 投稿20多天，编辑这直接拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Fri Dec 02 17:27:17 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1238224, encodeId=62a0123822440, content=不接受纯生信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=979b2249482, createdName=12160191m01暂无昵称, createdTime=Fri Aug 12 09:22:35 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996999, encodeId=0bba99699967, content=这个审稿快不快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65a15502615, createdName=皮皮02, createdTime=Wed Jul 07 08:57:36 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590587, encodeId=cdd159058eae, content=我刚投了，在技术审核阶段，不晓得能不能通过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Sun May 10 00:00:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567249, encodeId=3b8756e249dd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：一审阶段：2018.06.06~2018.08.20，被拒，接受修改后再投 二审阶段：2018.09.22~2018.11.08，被拒，接受修改后再投 三审阶段：2018.11.18~2018.12.08，被拒，不可再投 欢迎关住生信算法，一起交流学习，附审稿意见download，关注后回复bmc即可, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=NspicTOL6XtFWgupDw26HOw&s=100, createdBy=c81c2554596, createdName=生信算法公众号, createdTime=Mon Feb 25 17:49:00 CST 2019, time=2019-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077517, encodeId=a94810e7517db, content=唉，被transfer了，但杂志也没有说transfer到了哪里，说是系统的一个刊物, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daf95314919, createdName=1489665dm23暂无昵称, createdTime=Mon Dec 06 21:41:01 CST 2021, time=2021-12-06, status=1, ipAttribution=)]

2021-12-06 1489665dm23暂无昵称

唉，被transfer了，但杂志也没有说transfer到了哪里，说是系统的一个刊物

57 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务